BRIEF-Eleven Biotherapeutics buys Viventia Bio to create oncology company
September 21, 2016 at 07:52 AM EDT
* Eleven Biotherapeutics acquires Viventia Bio to create targeted protein therapeutics oncology company
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.